Codexis

News

CPhI 2014 Experts Statements: Dr. Jean-Luc Herbeaux, Head Business Line Health Care, Evonik

Topics • Strategy

Today’s Challenges, Tomorrow’s Excellence

News

Codexis Appoints Kathleen Glaub to Board of Directors

News

Codexis Enters into Technology Collaboration with GSK

Topics • Strategy

Potential In Eastern Europe

News

Codexis Reports First Quarter 2014 Financial Results

News

Codexis sells Hungarian operations to Intrexon Corporation

News

Codexis Reports Fourth Quarter and Full Year 2013 Results

News

Codexis announces Greg Hughes as Vice President Strategic Alliance & Product Development

Topics • Technology

Enzymes as a Catalytic All Rounder

Topics • Chemistry

Green Chemistry and the Chemical Industry

News

Codexis Reports Fourth Quarter and Full Year 2012 Results

Topics • Chemistry

Codexis Sees Success in Pharma Business...

News

Codexis Demonstrates Enzyme-Based Carbon Capture at NCCC

News

Codexis Selected for Presidential Green Chemistry Award

News

Codexis Appoints John J. Nicols as President and CEO

News

Codexis Sees Shell Move on Research Mid-year

News

Fine Chemicals Developing Well in 2011

News

DSM and Codexis Sign Enzyme Supply Agreement

News

Codexis Prices at Bottom of Range

News

Dishman Group Announces Strategic Alliance With Codexis

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Interview

Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Thomson Reuters

Codexis

Codexis

Top-Feature

Upcoming Virtual Events

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Siemens Joins the Global Impact Coalition

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Interview

Newsletter & e-edition